[2]
Borenstein JE,Dean BB,Leifke E,Korner P,Yonkers KA, Differences in symptom scores and health outcomes in premenstrual syndrome. Journal of women's health (2002). 2007 Oct
[PubMed PMID: 17937566]
[3]
Wittchen HU,Perkonigg A,Pfister H, Trauma and PTSD - an overlooked pathogenic pathway for premenstrual dysphoric disorder? Archives of women's mental health. 2003 Nov
[PubMed PMID: 14628182]
[4]
Bertone-Johnson ER,Hankinson SE,Johnson SR,Manson JE, Cigarette smoking and the development of premenstrual syndrome. American journal of epidemiology. 2008 Oct 15
[PubMed PMID: 18701443]
[5]
Bertone-Johnson ER,Hankinson SE,Willett WC,Johnson SR,Manson JE, Adiposity and the development of premenstrual syndrome. Journal of women's health (2002). 2010 Nov
[PubMed PMID: 20874240]
[6]
Dhingra V,Magnay JL,O'Brien PM,Chapman G,Fryer AA,Ismail KM, Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder. Obstetrics and gynecology. 2007 Oct
[PubMed PMID: 17906010]
[7]
Huo L,Straub RE,Roca C,Schmidt PJ,Shi K,Vakkalanka R,Weinberger DR,Rubinow DR, Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biological psychiatry. 2007 Oct 15
[PubMed PMID: 17599809]
[8]
Halbreich U,Borenstein J,Pearlstein T,Kahn LS, The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003 Aug
[PubMed PMID: 12892987]
[9]
Hylan TR,Sundell K,Judge R, The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. Journal of women's health
[PubMed PMID: 10565662]
[10]
Halbreich U, The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology. 2003 Aug
[PubMed PMID: 12892990]
[11]
Wyatt K,Dimmock P,Jones P,Obhrai M,O'Brien S, Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ (Clinical research ed.). 2001 Oct 6
[PubMed PMID: 11588078]
Level 1 (high-level) evidence
[12]
Cunningham J,Yonkers KA,O'Brien S,Eriksson E, Update on research and treatment of premenstrual dysphoric disorder. Harvard review of psychiatry. 2009
[PubMed PMID: 19373620]
[13]
Schmidt PJ,Nieman LK,Danaceau MA,Adams LF,Rubinow DR, Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. The New England journal of medicine. 1998 Jan 22
[PubMed PMID: 9435325]
[14]
Björn I,Sundström-Poromaa I,Bixo M,Nyberg S,Bäckström G,Bäckström T, Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. The Journal of clinical endocrinology and metabolism. 2003 May
[PubMed PMID: 12727949]
[15]
Dhar V,Murphy BE, Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Psychoneuroendocrinology. 1990
[PubMed PMID: 1966304]
Level 1 (high-level) evidence
[16]
Oksa S,Luukkaala T,Mäenpää J, Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study. BJOG : an international journal of obstetrics and gynaecology. 2006 Jun
[PubMed PMID: 16709215]
Level 1 (high-level) evidence
[17]
Brzezinski AA,Wurtman JJ,Wurtman RJ,Gleason R,Greenfield J,Nader T, d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstetrics and gynecology. 1990 Aug
[PubMed PMID: 2371034]
[18]
Su TP,Schmidt PJ,Danaceau M,Murphy DL,Rubinow DR, Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. The Journal of clinical endocrinology and metabolism. 1997 Apr
[PubMed PMID: 9100599]
[19]
Steinberg S,Annable L,Young SN,Liyanage N, A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biological psychiatry. 1999 Feb 1
[PubMed PMID: 10023508]
Level 1 (high-level) evidence
[20]
Menkes DB,Coates DC,Fawcett JP, Acute tryptophan depletion aggravates premenstrual syndrome. Journal of affective disorders. 1994 Sep
[PubMed PMID: 7798465]
[21]
Roca CA,Schmidt PJ,Smith MJ,Danaceau MA,Murphy DL,Rubinow DR, Effects of metergoline on symptoms in women with premenstrual dysphoric disorder. The American journal of psychiatry. 2002 Nov
[PubMed PMID: 12411222]
[22]
Bancroft J,Cook A,Davidson D,Bennie J,Goodwin G, Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychological medicine. 1991 May
[PubMed PMID: 1876635]
[23]
Eriksson O,Wall A,Marteinsdottir I,Agren H,Hartvig P,Blomqvist G,Långström B,Naessén T, Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria. Psychiatry research. 2006 Mar 31
[PubMed PMID: 16515859]
[24]
Halbreich U,Tworek H, Altered serotonergic activity in women with dysphoric premenstrual syndromes. International journal of psychiatry in medicine. 1993
[PubMed PMID: 8514462]
[25]
Smith SS,Ruderman Y,Frye C,Homanics G,Yuan M, Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5beta-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology. 2006 Jun
[PubMed PMID: 16193334]
[26]
Sundström Poromaa I,Smith S,Gulinello M, GABA receptors, progesterone and premenstrual dysphoric disorder. Archives of women's mental health. 2003 Feb
[PubMed PMID: 12715262]
[27]
Sundström I,Ashbrook D,Bäckström T, Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology. 1997 Jan
[PubMed PMID: 9141149]
Level 3 (low-level) evidence
[28]
Bhagwagar Z,Wylezinska M,Taylor M,Jezzard P,Matthews PM,Cowen PJ, Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. The American journal of psychiatry. 2004 Feb
[PubMed PMID: 14754790]
[29]
Sundström I,Bäckström T, Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology. 1998 Jan
[PubMed PMID: 9618754]
[30]
Pinna G,Costa E,Guidotti A, Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology. 2006 Jun
[PubMed PMID: 16432684]
[31]
Griffin LD,Mellon SH, Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proceedings of the National Academy of Sciences of the United States of America. 1999 Nov 9
[PubMed PMID: 10557352]
[32]
Batra NA,Seres-Mailo J,Hanstock C,Seres P,Khudabux J,Bellavance F,Baker G,Allen P,Tibbo P,Hui E,Le Melledo JM, Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biological psychiatry. 2008 Jun 15
[PubMed PMID: 18061146]
[33]
Straneva PA,Maixner W,Light KC,Pedersen CA,Costello NL,Girdler SS, Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 2002 Jul
[PubMed PMID: 12090678]
[34]
Joffe H,Kim DR,Foris JM,Baldassano CF,Gyulai L,Hwang CH,McLaughlin WL,Sachs GS,Thase ME,Harlow BL,Cohen LS, Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. The Journal of clinical psychiatry. 2006 Feb
[PubMed PMID: 16566627]
[35]
Young EA,Korszun A, The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinology and metabolism clinics of North America. 2002 Mar
[PubMed PMID: 12055991]
[36]
Pearlstein T,Yonkers KA,Fayyad R,Gillespie JA, Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal of affective disorders. 2005 Apr
[PubMed PMID: 15780697]
[37]
Meaden PM,Hartlage SA,Cook-Karr J, Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States. Psychiatry research. 2005 Mar 30
[PubMed PMID: 15808287]
[38]
Steiner M,Macdougall M,Brown E, The premenstrual symptoms screening tool (PSST) for clinicians. Archives of women's mental health. 2003 Aug
[PubMed PMID: 12920618]
[39]
Feuerstein M,Shaw WS, Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. The Journal of reproductive medicine. 2002 Apr
[PubMed PMID: 12012879]
[40]
Junghaenel DU,Schneider S,Stone AA,Christodoulou C,Broderick JE, Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue. Journal of psychosomatic research. 2014 Apr
[PubMed PMID: 24630180]
Level 2 (mid-level) evidence
[41]
Sundblad C,Hedberg MA,Eriksson E, Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 1993 Sep
[PubMed PMID: 8216696]
[42]
Sundblad C,Modigh K,Andersch B,Eriksson E, Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta psychiatrica Scandinavica. 1992 Jan
[PubMed PMID: 1546547]
[43]
Wikander I,Sundblad C,Andersch B,Dagnell I,Zylberstein D,Bengtsson F,Eriksson E, Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? Journal of clinical psychopharmacology. 1998 Oct
[PubMed PMID: 9790157]
[44]
Ravindran LN,Woods SA,Steiner M,Ravindran AV, Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series. Archives of women's mental health. 2007
[PubMed PMID: 17431739]
Level 2 (mid-level) evidence
[45]
Pearlstein TB,Stone AB,Lund SA,Scheft H,Zlotnick C,Brown WA, Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. Journal of clinical psychopharmacology. 1997 Aug
[PubMed PMID: 9241004]
[46]
Freeman EW,Rickels K,Sondheimer SJ,Polansky M, Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Archives of general psychiatry. 1999 Oct
[PubMed PMID: 10530636]
Level 1 (high-level) evidence
[47]
Sundblad C,Wikander I,Andersch B,Eriksson E, A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 1997 Aug
[PubMed PMID: 9213079]
[48]
Smith S,Rinehart JS,Ruddock VE,Schiff I, Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstetrics and gynecology. 1987 Jul
[PubMed PMID: 3299178]
Level 1 (high-level) evidence
[49]
Harrison WM,Endicott J,Nee J, Treatment of premenstrual dysphoria with alprazolam. A controlled study. Archives of general psychiatry. 1990 Mar
[PubMed PMID: 2407209]
[50]
Beck LE,Gevirtz R,Mortola JF, The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosomatic medicine. 1990 Sep-Oct
[PubMed PMID: 2247559]